INTERNATIONAL PATENT: UCB BIOPHARMA SRL FILES APPLICATION FOR "TREATMENT OF TAUOPATHIES WITH TAU-BINDING ANTIBODIES"

GENEVA, March 23 -- UCB BIOPHARMA SRL (Allee de la Recherche 601070 Brussels) filed a patent application (PCT/EP2025/076107) for "TREATMENT OF TAUOPATHIES WITH TAU-BINDING ANTIBODIES" on Sep 12, 2025. With publication no. WO/2026/057816, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GERMANI, Massimiliano (c/o UCB Biopharma SRLAllee de la Recherche 601070 Brussels), BUCHANAN, Timothy John (c/o UCB Biopharma SRLAllee de la Recherche 601070 Brussels), EWEN, Colin (c/o UCB Biopharma SRLAllee de la Recherche 601070 Brussels)...